Glutamate receptor (GluR) agonist, 2-chloro-5-hydroxyphenylglycine (CHPG), preserves primary myelination disrupted by intermittent hypoxia in neonatal mice.

Saturday, May 4, 2024

2:00 PM – 2:15 PM ET

Location: Metro Toronto Convention Centre: 103

CE Enduring CME: 0.25

Publication Number: 2155.1

Casey E. Lamar, Rutgers, Robert Wood Johnson Medical School, Highland Park, NJ, United States; Zoya Niatsetskaya, Rutgers, Robert Wood Johnson Medical School, New Brunswick, NJ, United States; Sergey Sosunov, Rutgers, Robert Wood Johnson Medical School, New Brunswick, NJ, United States; Yangyang Huang, Rutgers University-RWJMS, Piscataway, NJ, United States; Cheryl F. Dreyfus, Rutgers, Robert Wood Johnson Medical School, PISCATAWAY, NJ, United States; vadim S.. Ten, Rutgers/RWJMS, Staten Island, NY, United States

Presenting Author(s)

Casey E. Lamar, MD (he/him/his)
Resident Physician
Rutgers, Robert Wood Johnson Medical School
Highland Park, New Jersey, United States

Slides

Disclosure(s):

Casey E. Lamar, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Zoya Niatsetskaya, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Sergey Sosunov, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Yangyang Huang, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Cheryl F. Dreyfus, BS, MS, PhD: No relevant disclosure to display

Vadim S. Ten, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.